Microwave Hyperthermia Treatment for HPV E6 Protein Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Certain viral pathogens, such as Human Papillomavirus (HPV), interfere with the normal function of the p53 protein, leading to uncontrolled cell growth and cancer by inhibiting its expression and activity, which existing treatments often require a functional immune system to be effective.
Innovation Solution
The application of microwave energy induces localized hyperthermia in cells to degrade the HPV E6 protein, thereby restoring p53 function and expression, which can occur independently of the immune system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used to treat HPV infections, then treatment effectiveness depends on immune system functionality, but this limits treatment options for immunocompromised patients
Solution Approach 1:
The patent replaces immune system-dependent biological mechanisms with direct microwave energy application. The microwave energy directly degrades the E6 oncoprotein through thermal effects, bypassing the need for immune system involvement in the treatment mechanism, thereby making treatment effective for immunocompromised patients.
Solution Approach 2:
The patent changes the physical parameter of temperature through microwave energy application. By elevating tissue temperature to hyperthermic levels (40-45°C), the treatment directly denatures and degrades the E6 protein, creating a new treatment pathway that does not rely on immune system functionality.
2Reliability
If microwave energy is applied to degrade HPV E6 protein, then p53 function is restored and apoptosis is induced, but localized hyperthermia must be precisely controlled
Solution Approach 1:
The patent applies microwave energy in a highly localized manner to the infected tissue only. The energy delivery is focused on specific regions where HPV infection is present, creating localized hyperthermia that degrades E6 protein in target cells while maintaining normal temperature in surrounding healthy tissues through precise spatial control.
Solution Approach 2:
The microwave energy application can be delivered in periodic or pulsed intervals, allowing temperature to be elevated to therapeutic levels during treatment phases and then dissipated during intervals. This periodic action enables precise control over the degree and duration of hyperthermia, ensuring effective E6 degradation while preventing excessive temperature damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Microwave energy effectively degrades the HPV E6 protein, reactivating p53 and inducing apoptosis in infected cells, providing a treatment for HPV infections and associated cancers without relying on immune system functionality.
Implementation Method 1
The present disclosure provides methods based upon the use of microwave energy which may be used to treat and prevent infections as well as modulate p53 expression in infected cells
Implementation Method 2
the microwave energy creates at least a state of localised hyperthermia in a cell or tissue of the cervix, cancerous lesion or precancerous lesion thereof to degrade the HPV E6 protein
Implementation Method 3
the microwave energy degrades the HPV E6 protein
Implementation Method 4
reactivating p53 and inducing apoptosis in infected cells
Data Source
AI summary
A method of treating or preventing an HPV infection or a disease or condition associated with an HPV infection comprises exposing a subject with an HPV infection to microwave energy, where the microwave energy degrades the HPV E6 protein.